Unum
UNM NYSE Life & Health Insurance Financials FY2016βFY2025
Unum's revenue rose 1.5% to $13.1 billion in fiscal 2025. Its net margin was 5.7%, down from 13.8% a year earlier. Free cash flow was $555 million, down 60.0%. It paid out $1.3 billion in dividends and buybacks, 237% of free cash flow. The diluted share count fell 8.1%.
About these figures. Unum's filings tag a negative figure (a part of its equity) as its equity including minority owners, so its shareholders' equity is used throughout (Unum has no minority owners).
What Unum does
No business description yet.
- Legal name
- Unum Group
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000005513-26-000008
0000005513
Revenue and margins
Unum had $13.1B of revenue in fiscal 2025, up 1.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 0.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $555M in fiscal 2025, 4.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Unum returned $1.3B to shareholders in fiscal 2025, 237% of free cash flow. The diluted share count fell 8.1%.
Value Unum yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$593M and divides by 172.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 21.0x Β· peers 11.6x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Unum can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $1.5B | $1.8B | $2.7B | $3.2B |
| Debt incl. finance leases | $3.4B | $3.4B | $3.4B | $3.7B | $3.8B |
| Net debt / EBITDA | 1.3x | 0.9x | 0.9x | 0.4x | 0.5x |
| Debt / equity | 0.6x | 0.4x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 7.8x | 10.3x | 9.4x | 12.2x | 5.5x |
| Total assets | $70.1B | $61.1B | $63.3B | $62.0B | $63.5B |
| Total liabilities | $58.7B | $52.4B | $53.6B | $51.0B | $52.4B |
| Shareholders' equity | $6.0B | $8.7B | $9.7B | $11.0B | $11.1B |
| Net debt (β = net cash) | $2.0B | $1.9B | $1.7B | $1.0B | $593M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.5M
7 insiders
Of sales under plans
8%
$0.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Timothy F KeaneyDirector | Sold | 4,300 | $94.02 | $0.4M | Form 4 |
| Sep 10, 2026 | Walter Lynn Rice JRSVP, Chief Accounting Officer | Sold | 2,188 | $94.32 | $0.2M | Form 4 |
| Sep 9, 2026 | Lisa G IglesiasEVP, General Counsel | Sold | 4,000 | $94.44 | $0.4M | Form 4 |
| Apr 30, 2026 | Elizabeth Claire AhmedEVP, People & Communications | Sold | 12,000 | $80.14 | $1.0M | Form 4 |
| Mar 16, 2026 | Christopher W PyneEVP, Group Benefits | Sold plan | 4,852 | $72.47 | $0.4M | Form 4 |
| Mar 9, 2026 | Lisa G IglesiasEVP, General Counsel | Sold | 3,500 | $73.00 | $0.3M | Form 4 |
| Feb 18, 2026 | Cynthia EganDirector | Sold | 9,000 | $73.00 | $0.7M | Form 4 |
| Feb 18, 2026 | Timothy F KeaneyDirector | Sold | 4,500 | $72.58 | $0.3M | Form 4 |
| Dec 9, 2025 | Walter Lynn Rice JRSVP, Chief Accounting Officer | Sold | 900 | $73.50 | $0.1M | Form 4 |
| Nov 19, 2025 | Steven Andrew ZabelEVP, Chief Financial Officer | Sold | 7,500 | $76.38 | $0.6M | Form 4 |
| Nov 7, 2025 | Christopher W PyneEVP, Group Benefits | Sold | 4,000 | $78.04 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 0.1% | 0.4% | 0.1% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Unum UNM | $14.4B | 1.5% | β | 4.3% | 7.6% | 21.0x | β | |
| Principal Financial Group PFG | $23.9B | β3.1% | β | β | β | 15.6x | β | Compare β |
| Aflac AFL | $60.9B | β9.3% | β | β | 13.0% | 13.0x | β | Compare β |
| Brighthouse Financial BHF | $2.6B | 43.2% | β | β | β | 3.6x | β | Compare β |
| Globe Life GL | $12.2B | 3.7% | β | 20.9% | 16.0% | 10.3x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $11.0B | $11.3B | $11.6B | $12.0B | $13.2B | $12.0B | $12.0B | $12.4B | $12.9B | $13.1B |
| Interest expense | $166M | $160M | $167M | $177M | $188M | $185M | $189M | $195M | $201M | $209M |
| Pretax income | $1.3B | $1.4B | $628M | $1.4B | $964M | $1.3B | $1.8B | $1.6B | $2.3B | $934M |
| Income tax | $416M | $410M | $104M | $282M | $171M | $280M | $343M | $356M | $472M | $195M |
| Net income | $931M | $994M | $523M | $1.1B | $793M | $981M | $1.4B | $1.3B | $1.8B | $739M |
| Diluted EPS | $3.95 | $4.37 | $2.38 | $5.24 | $3.89 | $4.79 | $6.96 | $6.50 | $9.46 | $4.27 |
| Diluted shares | 0.24B | 0.23B | 0.22B | 0.21B | 0.20B | 0.20B | 0.20B | 0.20B | 0.19B | 0.17B |
| Cash flow | ||||||||||
| Cash from operations | $1.1B | $1.2B | $1.5B | $1.6B | $469M | $1.4B | $1.4B | $1.2B | $1.5B | $688M |
| Capital expenditure | $85.0M | $105M | $144M | $151M | $119M | $110M | $102M | $135M | $126M | $132M |
| Free cash flow | $1.0B | $1.1B | $1.4B | $1.5B | $350M | $1.3B | $1.3B | $1.1B | $1.4B | $555M |
| Depreciation and amortization | $102M | $103M | $101M | $110M | $114M | $120M | $111M | $109M | $116M | $123M |
| Stock-based compensation | $21.9M | $29.5M | $26.3M | $26.6M | $30.4M | $35.4M | $52.7M | $64.1M | $47.8M | $53.6M |
| Acquisitions | $129M | $0.0M | $145M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $405M | $402M | $356M | $400M | $0.0M | $50.0M | $200M | $250M | $973M | $1.0B |
| Dividends paid | $183M | $196M | $216M | $229M | $232M | $239M | $254M | $277M | $297M | $306M |
| Dividends and buybacks | $588M | $598M | $572M | $630M | $232M | $289M | $454M | $527M | $1.3B | $1.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $880M | $1.2B | $1.1B | $1.4B | $1.7B | $1.5B | $1.5B | $1.8B | $2.7B | $3.2B |
| Total debt | $3.0B | $2.9B | $3.0B | $3.3B | $3.3B | $3.4B | $3.4B | $3.4B | $3.7B | $3.8B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $501M | $505M | $547M | $534M | $498M | $463M | $452M | $485M | $488M | $504M |
| Total assets | $61.9B | $64.0B | $61.9B | $67.0B | $70.6B | $70.1B | $61.1B | $63.3B | $62.0B | $63.5B |
| Total liabilities | $53.0B | $54.4B | $53.3B | $57.0B | $59.8B | $58.7B | $52.4B | $53.6B | $51.0B | $52.4B |
| Shareholders' equity | $9.0B | $9.6B | $8.6B | $10.0B | $10.9B | $6.0B | $8.7B | $9.7B | $11.0B | $11.1B |
| Margins | ||||||||||
| EBITDA margin | 14.6% | 14.8% | 7.7% | 13.9% | 9.6% | 13.0% | 17.1% | 15.7% | 19.9% | 9.7% |
| Net margin | 8.4% | 8.8% | 4.5% | 9.2% | 6.0% | 8.2% | 11.7% | 10.4% | 13.8% | 5.7% |
| FCF margin | 9.4% | 9.4% | 12.0% | 12.1% | 2.7% | 10.6% | 11.0% | 8.6% | 10.8% | 4.3% |
| Returns | ||||||||||
| Return on capital | 9.7% | 9.9% | 6.1% | 11.1% | 7.8% | 10.9% | 16.7% | 13.1% | 16.6% | 7.6% |
| Return on equity | 10.6% | 10.7% | 5.8% | 11.8% | 7.6% | 11.6% | 19.1% | 14.0% | 17.3% | 6.7% |
| Return on assets | 1.5% | 1.6% | 0.8% | 1.7% | 1.2% | 1.4% | 2.1% | 2.1% | 2.8% | 1.2% |
| Growth | ||||||||||
| Revenue growth | 2.9% | 2.2% | 2.8% | 3.5% | 9.7% | β8.8% | β0.2% | 3.4% | 4.1% | 1.5% |
| Net income growth | 7.4% | 6.7% | β47.4% | 110.2% | β27.9% | 23.7% | 43.5% | β8.8% | 38.6% | β58.5% |
| EPS growth | 12.9% | 10.6% | β45.5% | 120.2% | β25.8% | 23.1% | 45.3% | β6.6% | 45.5% | β54.9% |
| FCF growth | β13.0% | 2.1% | 31.5% | 4.6% | β75.9% | 264.7% | 3.1% | β18.9% | 29.9% | β60.0% |
| Share count change | β4.8% | β3.7% | β3.2% | β4.6% | β2.9% | 0.5% | β1.3% | β2.2% | β4.8% | β8.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.3x | 1.0x | 2.1x | 1.2x | 1.3x | 1.3x | 0.9x | 0.9x | 0.4x | 0.5x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x | 0.6x | 0.4x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 9.1x | 9.8x | 4.8x | 8.8x | 6.1x | 7.8x | 10.3x | 9.4x | 12.2x | 5.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.8% | 0.9% | 1.2% | 1.3% | 0.9% | 0.9% | 0.9% | 1.1% | 1.0% | 1.0% |
| Stock comp / revenue | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.3% | 0.4% | 0.5% | 0.4% | 0.4% |
| Payouts / FCF | 56.7% | 56.5% | 41.1% | 43.2% | 66.2% | 22.7% | 34.5% | 49.4% | 91.5% | 237.0% |
| Quality scores | ||||||||||
| Accruals ratio | β0.3% | β0.3% | β1.6% | β0.8% | 0.5% | β0.6% | β0.0% | 0.1% | 0.4% | 0.1% |
Source: SEC EDGAR XBRL filings (CIK 0000005513). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.